Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System

Published:2020-05-07 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Mascolo Annamaria,Scavone Cristina,Bertini Michele,Brusco Simona,Punzo Francesca,Pota Elvira,Di Martino Martina,Di Pinto Daniela,Rossi Francesca

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference72 articles.

1. Prescribing of medicines in the Danish paediatric population outwith the licensed age group: Characteristics of adverse drug reactions;Aagaard;Br. J. Clin. Pharmacol.,2011

2. Improving the outcome for children with cancer: Development of targeted new agents;Adamson;CA Cancer J. Clin.,2015

3. Treatment of children with relapsed and refractory acute lymphoblastic leukemia with mitoxantrone, vincristine, pegaspargase, dexamethasone, and bortezomib;August;Pediatr. Blood Cancer,2020

4. Adverse drug reactions and off-label and unlicensed medicines in children: A prospective cohort study of unplanned admissions to a paediatric hospital;Bellis;Br. J. Clin. Pharmacol.,2014

5. The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood;Bertaina;Br. J. Haematol.,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of Off-Label Use of Anticancer Drugs in Oncology;Creative surgery and oncology;2024-04-18

2. The experience with Brentuximab vedotin in the treatment of lymphomatoid papulosis in a pediatric patient;Russian journal of hematology and transfusiology;2024-03-19

3. Analysis of medical malpractice liability disputes related to novel antineoplastic drugs and research on risk prevention and control strategies;PLOS ONE;2023-06-05

4. Investigation of Single and Multiple Mutations Prediction Using Binary Classification Approach;Intelligent Automation & Soft Computing;2023

5. The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis;Frontiers in Pediatrics;2022-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3